Published in J Virol on May 18, 2011
Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science (2013) 1.27
Human cytomegalovirus persistence. Cell Microbiol (2012) 1.16
Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc Natl Acad Sci U S A (2012) 1.07
Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells. PLoS Pathog (2013) 0.99
Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J Virol (2013) 0.98
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol (2014) 0.95
Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses (2012) 0.94
The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol (2014) 0.85
Infection history determines the differentiation state of human CD8+ T cells. J Virol (2015) 0.84
Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence (2012) 0.84
Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch. Elife (2015) 0.83
Human cytomegalovirus manipulation of latently infected cells. Viruses (2013) 0.81
Vaccination against a virus-encoded cytokine significantly restricts viral challenge. J Virol (2013) 0.81
Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells. J Virol (2015) 0.79
Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol (2014) 0.79
Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus. Front Microbiol (2014) 0.79
Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus. Front Microbiol (2016) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
Cytomegalovirus latency and reactivation: recent insights into an age old problem. Rev Med Virol (2015) 0.78
Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in Monocytes. J Virol (2016) 0.78
Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway. J Gen Virol (2015) 0.78
HCMV Displays a Unique Transcriptome of Immunomodulatory Genes in Primary Monocyte-Derived Cell Types. PLoS One (2016) 0.76
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein. Nat Commun (2017) 0.75
Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection. J Virol (2016) 0.75
Mechanisms modulating immune clearance during human cytomegalovirus latency. Proc Natl Acad Sci U S A (2012) 0.75
Exploiting viral natural history for vaccine development. Med Microbiol Immunol (2015) 0.75
Herpesviral capture of immunomodulatory host genes. Virus Genes (2017) 0.75
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med (1989) 5.65
Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature (1979) 5.58
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (1997) 5.17
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell (1997) 3.99
Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity (2008) 3.94
Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology (1994) 3.46
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A (2000) 2.83
Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol (1994) 2.68
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A (2005) 2.34
Isolation and characterization of human peripheral blood dendritic cells. J Immunol (1993) 2.33
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol (1994) 2.31
Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol (1996) 2.22
Quantitative analysis of latent human cytomegalovirus. J Virol (1999) 2.11
Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A (1997) 2.11
Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98
TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol (1996) 1.87
Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood (2007) 1.73
Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ (1989) 1.70
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65
TGF-beta1 regulation of dendritic cells. Microbes Infect (1999) 1.60
Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol (2004) 1.60
TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol (1992) 1.60
Primate cytomegaloviruses encode and express an IL-10-like protein. Virology (2000) 1.58
A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol (2004) 1.57
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol (2009) 1.49
Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood (2004) 1.49
Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol (2004) 1.43
Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol (2004) 1.34
Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol (2005) 1.32
Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton (2004) 1.31
Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J Virol (2009) 1.29
Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. Blood (1997) 1.24
Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J Virol (2008) 1.22
Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood (2006) 1.22
CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol (1999) 1.15
Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol (1999) 1.13
TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol (1997) 1.13
Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology (2008) 1.08
CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08
Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol (2010) 1.05
Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology (2009) 1.04
The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes. J Virol (2006) 0.99
Cytomegalovirus interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells. Viral Immunol (2006) 0.90
Generation of dendritic cells from peripheral blood adherent cells in medium with human serum. Scand J Immunol (1998) 0.88
Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. Virus Res (2007) 0.86
Enhanced monocyte Fc phagocytosis by a homologue of interleukin-10 encoded by human cytomegalovirus. Virology (2009) 0.81
Analysis of methods for the generation of dendritic cells from human peripheral blood monocytes. Yonsei Med J (2000) 0.79
Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus. Transplant Proc (2001) 0.78
Interleukin-3 in cooperation with transforming growth factor beta induces granulocyte macrophage colony stimulating factor independent differentiation of human CD34+ hematopoietic progenitor cells into dendritic cells with features of Langerhans cells. J Invest Dermatol (2003) 0.77
Effect of interleukin-10 on the phenotype and function of cultured human dendritic cells. Chin Med J (Engl) (2005) 0.76
A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol (2004) 1.57
Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J Virol (2006) 1.54
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol (2009) 1.49
Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol (2005) 1.48
Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol (2003) 1.23
Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood (2006) 1.22
Productive varicella-zoster virus infection of cultured intact human ganglia. J Virol (2007) 1.22
Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia. J Virol (2010) 1.08
Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology (2008) 1.08
Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol (2010) 1.05
Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells. J Virol (2011) 1.01
Characterization of the host immune response in human Ganglia after herpes zoster. J Virol (2010) 1.00
Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection. J Virol (2010) 0.98
Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J Virol (2013) 0.98
T-cell infiltration correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus. J Virol (2012) 0.97
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol (2004) 0.97
HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood (2009) 0.96
Varicella zoster virus immune evasion strategies. Curr Top Microbiol Immunol (2010) 0.96
Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses (2012) 0.94
Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci (2010) 0.94
Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J Virol (2010) 0.93
Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J Virol (2013) 0.92
Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1. J Immunol (2008) 0.92
Viruses and Langerhans cells. Immunol Cell Biol (2010) 0.91
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood (2002) 0.90
Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology (2007) 0.90
PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest (2013) 0.90
Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis. Tuberculosis (Edinb) (2009) 0.86
Experimental models to study varicella-zoster virus infection of neurons. Curr Top Microbiol Immunol (2010) 0.85
Varicella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-κB activity. J Virol (2011) 0.85
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Microarrays for the study of viral gene expression during human cytomegalovirus latent infection. Methods Mol Med (2008) 0.82
Koi herpesvirus encodes and expresses a functional interleukin-10. J Virol (2012) 0.81
Enhanced monocyte Fc phagocytosis by a homologue of interleukin-10 encoded by human cytomegalovirus. Virology (2009) 0.81
Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol (2011) 0.80
CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant. J Biol Chem (2012) 0.78
Dendritic cell biology in herpesvirus infections. Viral Immunol (2005) 0.78
Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures. J Virol (2013) 0.75
Inhibition of integrin α6 expression by cell-free varicella-zoster virus. J Gen Virol (2012) 0.75